| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO &President | CEO And President | Chief Financial Officer +1 more
2 companies
Shukla Sath is a CEO &President at Spero Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $5.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | SPRO Spero Therapeutics, Inc. | CEO &President | Sell | 155,333 | $0.78 | $121,159.74 | -2.8% | -32.7% | +162.3% | |
| Aug 27, 2024 | SPRO Spero Therapeutics, Inc. | CEO &President | Sell | 2,757 | $1.35 | $3,721.95 | -0.2% | -16.7% | +43.5% | |
| Aug 5, 2024 | SPRO Spero Therapeutics, Inc. | CEO And President | Sell | 32,441 | $1.31 | $42,645.71 | -1.4% | -3.7% | +58.2% | |
| Feb 5, 2024 | SPRO Spero Therapeutics, Inc. | CEO And President | Sell | 75,994 | $1.42 | $107,719.22 | -3.1% | +15.3% | -47.7% | |
| Aug 29, 2023 | SPRO Spero Therapeutics, Inc. | CEO And President | Sell | 6,017 | $1.29 | $7,747.94 | -0.5% | -14.6% | 0.0% | |
| Feb 2, 2023 | SPRO Spero Therapeutics, Inc. | Chief Financial Officer | Sell | 9,504 | $1.83 | $17,372.36 | -3.0% | -1.1% | -20.5% | |
| Aug 29, 2022 | SPRO Spero Therapeutics, Inc. | Chief Financial Officer | Sell | 6,017 | $0.89 | $5,377.99 | -9.7% | +117.0% | +55.7% |